The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines

United States, 2021

Sarah Mbaeyi, MD; Sara E. Oliver, MD; Jennifer P. Collins, MD; Monica Godfrey, MPH; Neela D. Goswami, MD; Stephen C. Hadler, MD; Jefferson Jones, MD; Heidi Moline, MD; Danielle Moulia, MPH; Sujan Reddy, MD; Kristine Schmit, MD; Megan Wallace, DrPH; Mary Chamberland, MD; Doug Campos-Outcalt, MD; Rebecca L. Morgan, PhD; Beth P. Bell, MD; Oliver Brooks, MD; Camille Kotton, MD; H. Keipp Talbot, MD; Grace Lee, MD; Matthew F. Daley, MD; Kathleen Dooling, MD


Morbidity and Mortality Weekly Report. 2021;70(44):1545-1552. 

In This Article

Reporting of Vaccine Adverse Events

FDA requires that immunization providers report vaccine administration errors, serious adverse events, cases of multisystem inflammatory syndrome, and cases of COVID-19 that result in hospitalization or death after administration of COVID-19 vaccine under an EUA.[2] Adverse events that occur after receipt of any COVID-19 vaccine should be reported to the Vaccine Adverse Events Reporting System (VAERS, or 1-800-822-7967). Any person who administers or receives a COVID-19 vaccine is encouraged to report any clinically significant adverse event, whether or not it is clear that a vaccine caused the adverse event. In addition, CDC has developed a new, voluntary smartphone-based online tool (v-safe) that uses text messaging and online surveys to provide near real-time health check-ins after receipt of a COVID-19 vaccine (